EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] Post-marketing Surveillance in Japan
Status:
Completed
Trial end date:
2017-02-27
Target enrollment:
Participant gender:
Summary
The objective of this survey is to evaluate effectiveness of EYLEA on Quality of Life (QOL).
The QOL is evaluated by using Japanese version (v.1.4 - interviewer administered format) of
National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) and compared at baseline
and at the 6 and 12 months after start of EYLEA treatment.